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Abstract
The SIR (susceptible–infectious–resistant) and SIS (susceptible–infectious–susceptible) frameworks for infectious disease have
been extensively studied and successfully applied. They implicitly assume the upper and lower limits of the range of possibilities for
host immune response. However, the majority of infections do not fall into either of these extreme categories. We combine two
general avenues that straddle this range: temporary immune protection (immunity wanes over time since infection), and partial
immune protection (immunity is not fully protective but reduces the risk of reinfection). We present a systematic analysis of the
dynamics and equilibrium properties of these models in comparison to SIR and SIS, and analyse the outcome of vaccination
programmes. We describe how the waning of immunity shortens inter-epidemic periods, and poses major difﬁculties to disease
eradication. We identify a ‘‘reinfection threshold’’ in transmission when partial immunity is included. Below the reinfection
threshold primary infection dominates, levels of infection are low, and vaccination is highly effective (approximately an SIR model).
Above the reinfection threshold reinfection dominates, levels of infection are high, and vaccination fails to protect (approximately
an SIS situation). This association between high prevalence of infection and vaccine failure emphasizes the problems of controlling
recurrent infections in high-burden regions. However, vaccines that induce a better protection than natural infection have the
potential to increase the reinfection threshold, and therefore constitute interventions with a surprisingly high capacity to reduce
infection where reduction is most needed.
r 2004 Elsevier Ltd. All rights reserved.
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1. Introduction
Mathematical epidemiological models for the dy-
namics of microparasite infections that induce lifelong
immunity have been extensively developed (Kermack
and McKendrick, 1927; Anderson and May, 1991;
Grenfell et al., 2001) and used as predictive tools to
assist in the design of control programmes (Osborne
et al., 2000). This class of infections is viral and usually
occurs during childhood (if there is no vaccination
occurring), which is indicative of high transmissibility.
Such effective immunity is observed in infections such
as measles, mumps and rubella (MMR) but this is
unusual. More common is the occurrence of several
reinfections throughout life. In similar vein to char-73ing author. Tel.: +351-214-464-626; fax: +351-214-
ess: ggomes@igc.gulbenkian.pt (M.G.M. Gomes).
e front matter r 2004 Elsevier Ltd. All rights reserved.
i.2004.02.015acterization of a vaccine response (McLean and Blower,
1993), susceptibility to reinfection following a primary
infection can be attributed to a combination of two
factors: immune protection may wane over time
(temporary immunity), or immunity may not be fully
protective (partial immunity). Both effects are likely due
to a combination of host insufﬁciency in acquiring and
maintaining speciﬁc immunity (e.g. tuberculosis—Vyn-
nycky and Fine, 1997; pertussis—Hethcote, 1999; van
Boven et al., 2000) and of pathogen ability to generate
antigenic diversity thereby avoiding immune recognition
(e.g. inﬂuenza—Hay et al., 2001; Earn et al., 2002;
respiratory syncytial virus—Cane, 2001).
The speciﬁc within-host mechanisms allowing recur-
rent infections are not explicit in this paper. Rather, we
construct a series of simple models to investigate the
epidemiological consequences of varying the duration
and degree of immune protection. The models are
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systematically analysed and reveal two main outcomes:
the duration of immunity has a crucial impact on
potential inter-epidemic periods; the degree of immune
protection determines a reinfection threshold in trans-
mission responsible for a steep increase in the prevalence
of infection. The models are then extended to analyse
the effects of temporary and partial immunity on the
global impact of vaccination programmes.
Mathematical models have long been associated with
the planning of vaccination programmes. The main
contributions have been the prediction of the vaccina-
tion coverage necessary to eradicate infections (Nokes
and Anderson, 1992, 1993), and the illustration of the
post-vaccination dynamics if coverage does not meet the
eradication threshold (McLean, 1995a). McLean and
Blower (1993) have also investigated the consequences
of vaccine failures, but under the assumption that
immunity induced by natural infection was fully
protective. Here this assumption is relaxed to accom-
modate the recurrence of infections. In the case of
temporary protection, we reach the same basic conclu-
sion that the waning of immunity is a major obstacle to
disease eradication even if individuals are protected until
very late in their lifetime. In the case of partial
protection, our conclusions are fundamentally different
due to reinfection threshold. Below the reinfection
threshold, levels of infection are low and vaccination
impact is high. The transmission dynamics are essen-
tially described by the susceptible–infected–recovered
(SIR) framework. Populations where transmissibility is
above the reinfection threshold are of greater concern.
They sustain very high endemicities and vaccination
programmes are unable to increase natural immunity
further. The transmission dynamics are essentially
susceptible–infected–susceptible (SIS). The transition
between the two regimes happens over a short range in
transmission coefﬁcient, indicating high sensitivity to
changes.
Throughout this paper we assume that birth and
death rates are equal ensuring a constant host popula-
tion size, the duration of infection is typically two orders
of magnitude lower than the host lifetime, and the
periods of infection and infectiousness coincide. Vacci-
nation programmes are implemented at birth. These
assumptions simplify the model analysis and do not
induce unwanted effects.N 103
105
107
109
111
Table 1
Model parameters when time is measured in years
Symbol Deﬁnition Value
m Death rate and, equally, birth rate 1/70 year1
t Rate of recovery from infection 12 year1
b Transmission coefﬁcient VariableU2. SIR and SIS models
The essence of infectious disease dynamics can be
represented by simple systems of ordinary differential
equations (Anderson and May, 1991; Diekmann and
Heesterbeek, 2000). The host population is assumed
homogeneous at birth and differentiation occurs as a
result of infection experience. The population isD P
RO
OF
assumed to mix homogeneously and transmission is
according to the mass-action principle. Hosts are
divided into three proportions: susceptible (S), infec-
tious (I), and recovered (R). Under the assumption that
recovered individuals acquired some immunity that is
totally protective and lifelong, we obtain the so-called
SIR model formalized by the system of differential
equations
dS
dT
¼ m bIS  mS;
dI
dT
¼ bIS  ðtþ mÞI ;
dR
dT
¼ tI  mR: ð1Þ
As in Table 1, the parameter m is the death rate (and
equally, the birth rate), t is the rate of recovery from
infection, and b is a transmission coefﬁcient which
combines a variety of epidemiological, environmental,
and social factors that affect transmission. Susceptible
individuals acquire infection at per capita rate bI : If
time, T, is measured in years, hosts are born with a life
expectancy of
L ¼
1
m
years
and we assume throughout that L=70 years. The
average duration of infection is
D ¼
1
tþ m
years
and we assume throughout that D is approximately 1
month. The last equation of model (1) can be omitted by
recalling that S+I+R=1.
2.1. Non-dimensional SIR model
The SIRmodel can be further simpliﬁed, resulting in a
reduction in the number of parameters. Measuring time
in units of duration of infection, t=T/D, we get the non-
dimensional system (see Table 2)
dS
dt
¼ e R0IS  eS;
dI
dt
¼ R0IS  I : ð2Þ
The ﬁrst parameter,
e ¼
D
L
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Table 2
Model parameters when time is measured in units of average duration of infection, D=1/(t+m)
Symbol Deﬁnition Value
e Death and birth rate, m/(t+m) 0.0012D1
R0 Basic reproduction number, b/(t+m) Variable
a Factor affecting the rate of loss of acquired immune protection Between 0 and 1
s Factor affecting the degree of partial immunity induced by a previous infection Between 0 and 1
sV Factor affecting the degree of partial immunity induced by vaccination Between 0 and 1
v Vaccination coverage 90%
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YJTBI : 3550represents the average duration of an infectious episode,
expressed as a proportion of average lifetime. For the
values of L and D above we get the approximate value
of e=0.0012. The second parameter,
R0 ¼ bD
represents the number of secondary cases expected from
a primary case in a completely susceptible population.
This is the so-called basic reproduction number, and is a
crucial parameter that will be thoroughly explored. The
SIR model with the new time units is represented
diagrammatically in Fig. 1(a). The model has two
possible steady states R 81(1) Disease-free equilibrium: S1=1, I1=0.
(2) Endemic equilibrium: S2=1/R0, I2=e(1(1/R0)).ED
 P 83
85
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Fig. 1. Flow diagram for all the models analysed in this paper. Time is
in units of average duration of infection and the parameters are
described in Table 1. For simplicity, births and deaths are not
represented.EC
T
The disease-free equilibrium, (S1, I1), is a valid steady
state independently of the value of R0, but the endemic
equilibrium, (S2, I2), requires R0>1. The number of
steady states changes at R0=1, and this is a bifurcation
point. The stability of (Si, Ii) is determined by the
eigenvalues of the Jacobian matrix
Ji ¼
R0Ii  e R0Si
R0Ii R0Si  1
 !
for i=1, 2. A straightforward calculation gives the
following results:95(1) REigenvalues of J1: e and R01.
(2)97REigenvalues of J2: eR07 ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃe2R204e R01ð Þp 2 .
99
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The eigenvalues of J1 are always real, and from their
signs we infer that the steady state (S1, I1) is stable for
R0o1, and unstable for R0>1. The eigenvalues of J2
have negative real part for the whole range of validity of
the steady state (S2, I2), implying that this steady state is
always stable. The eigenvalues are real for R0 just above
1, and become complex for R0 between ð2=eÞð1ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1 e
p
Þ and ð2=eÞð1þ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1 e
p
Þ implying convergence
in the form of damped oscillations in this range (for
e=0.0012, this is 1.0003oR0o3332). The vector ﬁeld is
illustrated in Fig. 2(a) for the particular case R0=3.
Superimposed is a simulation starting near the disease-
free equilibrium illustrating how the disease invades and
converges to the endemic equilibrium. Fig. 2(b) showsthe time-series plot corresponding to the same simula-
tion. Convergence is in the form of damped oscillations:
a series of epidemics of sequentially reducing amplitude
occur until the system approaches the endemic equili-
brium. A number of mechanisms have been identiﬁed as
capable of sustaining the oscillations (Liu et al., 1987),
enhancing the importance of quantifying the inter-
epidemic periods.
2.2. Non-dimensional SIS model
Variations of the SIR model have been developed to
incorporate features of particular diseases (Anderson
and May, 1991). Here, we consider diseases that fail to
elicit protective immunity, allowing recurrent infections.
In this extreme case, recovered hosts return to the
susceptibility class and the recovered class remains
empty so that S+I=1. The dynamics of this system
are driven by a one-dimensional system: the SIS model,
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Fig. 2. Vector ﬁeld and simulated solution corresponding to the SIR and SIS models for R0=3. (a) two-dimensional vector ﬁeld of SIR model, the
two steady states (open circle is unstable, and full circle is stable), and a simulated solution with initial condition near the unstable disease-free state;
(b) time series corresponding to the same simulated solution; (c) one-dimensional vector ﬁeld of SIS model, the two steady states, and a simulated
solution with initial condition near the unstable disease-free state; (d) time series corresponding to the same simulated solution.
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Fig. 3. Bifurcation diagram for the SIR, SIS, and intermediate
models. The extreme SIR and SIS models are represented by the lower
and higher full curves, respectively. Temporary immunity is repre-
sented by the dashed line, and partial immunity is represented by the
dotted line. Note the logarithmic scale on the vertical axis.
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dI
dt
¼ R0Ið1 IÞ  I : ð3Þ
Also here, there is a disease-free equilibrium (S= 1, I=
0) for all values of R0. Stability analysis shows that this
steady state is stable for R0o1 and unstable for R0>1.
As R0 is increased across one, a branch of endemicD Pequilibria bifurcates. At the endemic steady state wehave S=1/R0 and I=11/R0. In Fig. 2(c) and (d), we ﬁxR0=3 to represent the vector ﬁeld associated with the
SIS model and a simulation to illustrate convergence to
the steady state. The bifurcation diagrams correspond-
ing to both the SIR and SIS models are shown as the
full lines in Fig. 3, setting the lower and upper bounds to
the intermediate models.3. Intermediate models
3.1. Temporary immune protection
Pertussis is a highly contagious infection of the
respiratory tract where recurrence has been attributed
to the waning of immunity (Hethcote, 1999; van Boven
et al., 2000). Control by vaccination is less successful
than for other childhood diseases, and recent trends are
for overall increase, and occasionally strong epidemic
outbreaks.
The temporary immunity model is represented dia-
grammatically in Fig. 1(c). Our assumption is that, upon
infection, individuals develop an immune response that
is lost at a certain rate. The parameter a is introduced to
control the rate of loss of immunity. The model
equations are
E
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Fig. 4. Equilibria and convergence for the temporary immunity and partial immunity models. (a) and (b) refer to temporary immunity: (a) shows the
endemic equilibrium as a function of R0 and a indicating whether convergence is by damped oscillations (light grey) or linear decay (dark grey); and
(b) shows contour plots for the period of the oscillations in the damped oscillatory region (the labels represent years). (c) and (d) provide the same
information for partial immunity: (c) shows the endemic equilibrium as a function of R0 and s; and (d) shows contour plots for the period of the
oscillations.
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dS
dt
¼ e R0IS  eS þ að1 eÞð1 SÞ;
dI
dt
¼ R0IS  I : ð4Þ
The new parameter can take values between 0 and 1. In
the limit a=0, the rate of loss of immunity equals the
death rate (SIR limit). In the limit a=1, the rate of loss
of immunity equals the rate of loss of infectiousness
(SIS limit). The equilibrium curve for a= 0.04 is
represented as a dashed line in Fig. 3. Fig. 4(a) shows
the stable endemic equilibrium as a function of R0 and a
indicating whether convergence is by damped oscilla-
tions (light grey) or linear decay (dark grey). Fig. 4(b)
shows the contour plots for the period of the oscillations
in the damped oscillatory region (with time rescaled
back to years). Naturally, waning of immunity has a
crucial impact on the time-scale for potential oscillatory
dynamics.
3.2. Partial immune protection
There are many infections motivating the study of
partial immune protection. Inﬂuenza A and B viruses
cause the same respiratory disease, but exhibit contrast-
ing evolutionary features (Hay et al., 2001). Partial
immunity across antigenic variants is a principal playerDin models designed to study inﬂuenza evolution (An-
dreasen et al., 1997; Ferguson et al., 2003; Gog and
Grenfell, 2002; Gomes et al., 2004b). Other pathogens
invoking partial immunity include Neisseria meningitidis
(Gupta and Maiden, 2001), Streptococcus pneumoniae
(Lipsitch, 1997), and Mycobacterium tuberculosis (Vyn-
nycky and Fine, 1997; Gomes et al., 2004a).
The partial immunity model is represented diagram-
matically in Fig. 1(d) and formalized by the system of
equations
dS
dt
¼ e R0IS  eS;
dI
dt
¼ R0IðS þ sð1 S  IÞÞ  I : ð5Þ
The new assumption is that individuals are protected
while infected but regain some susceptibility upon
recovery. This susceptibility is reduced by a factor s;
compared to susceptibility prior to infection. The limit
s ¼ 0 is an SIR model, and the limit s ¼ 1 is an SIS
model. The equilibrium curve for s ¼ 0:4 is represented
as a dotted line in Fig. 3. Fig. 4(c) shows the stable
endemic equilibrium as a function of R0 and s indicating
whether convergence is by damped oscillations (light
grey) or linear decay (dark grey). Fig. 4(d) shows the
contour plots for the period of the oscillations in the
damped oscillatory region (in years). The ﬁgure reveals
EOF
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Fig. 5. Schematic diagram illustrating the position of the SIR and SIS
frameworks in the parameter space (a,s) characterizing temporary-
partial immune protection.
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two clearly distinct types of endemic behaviour: low and
potentially oscillatory; and high and steady. Roughly,
the ﬁrst requires that transmissibility is above the
threshold for disease persistence (R0>1), and the second
relies on reinfection requiring that transmissibility is
above a higher threshold (R0>1/s).
3.3. Temporary-partial immunity
We used the dynamics of pertussis as an example of
temporary immunity, and we evoked a number of
infections as examples of partial immunity. However,
the transmission dynamics of each of these infections is
likely to be associated with a speciﬁc combination of
both temporary and partial immunity processes, as
recently analysed for respiratory syncytial virus (White
et al., 2004). We construct a general framework where
the contributions of the two mechanisms are combined.
The temporary-partial immunity model is represented
by the diagram in Fig. 1(e). As before, a is a parameter
that controls the rate of loss of immune protection, and
s controls the degree of protection that individuals
acquire upon recovery from infection. The model
equations are
dS
dt
¼ e R0IS  eS þ að1 eÞð1 SÞ;
dI
dt
¼ R0IðS þ sð1 S  IÞÞ  I : ð6Þ
Fig. 5 illustrates the position of SIR and SIS frame-
works in the parameter space (a, s) that characterizes
temporary-partial immune protection. The SIR model is
retrieved at a=0 and s=0, and the SIS model
corresponds to a=1 or s=1. The temporary immunity
model is retrieved at s=0, and the partial immunity
model is obtained at a=0. As observed in Fig. 4, a
temporary immunity mechanism has a strong impact on
potential epidemic dynamics, and a partial immunity
mechanism induces a second transmission threshold
separating regions of low-oscillating and high-steady
endemicity. Here, we analyse the combined effects of
these two mechanisms. Fig. 6 illustrates how the
behaviour of the system depends on a and s for three
ﬁxed values of R0. Fig. 6(a), (c) and (e) show the stable
endemic equilibrium, for R0=3.5, 4.0, 4.5, respectively,
indicating whether convergence is by damped oscilla-
tions (light grey) or linear decay (dark grey). The
respective contour plots for the period of the oscillations
are shown in Fig. 6(b), (d) and (f).107
109
1114. Temporary immune protection and vaccination
We proceed to illustrate the impact of mass vaccina-
tion at birth under the temporary immunity model. The
model, which assumes that protection induced by theD P
ROvaccine is equivalent to protection acquired in responseto natural infection, is formalized by the system of
equations
dS
dt
¼ ð1 vÞe R0IS  eS þ að1 eÞð1 SÞ;
dI
dt
¼ R0IS  I ; ð7Þ
where the new parameter, v, represents coverage of the
vaccination programme. Fig. 7 illustrates the effect of
vaccination in this system when a=0.0015. In this case,
the average duration of immunity, 1/a(1e), corre-
sponds to approximately 55 years to represent the loss of
immunity commonly observed late in life (which is
sometimes observed, even for SIR type infections). The
full curves in Fig. 7(a) represent the endemic equilibrium
without vaccination (top curve) and when the system is
subject to a mass vaccination programme with 90%
coverage (bottom curve). The dashed line represents the
unrealistic limit of 100% vaccination coverage. The
dashed line meets the R0-axis at the critical value:
R0a ¼ 1þ
e
að1 eÞ
implying that eradication is possible only if, in the
absence of vaccination, R0 is lower than this threshold.
For the parameter values set here, R0a is approximately
1.84. This appears remarkably low when we note that in
the idealized situation of lifelong immunity, a=0, the
eradication threshold would be pushed to inﬁnity,
implying that the infection could always be eradicated
by vaccination as long as the coverage was sufﬁciently
high (i.e. greater than 11/R0). Fig. 7(b) shows the
result of simulations with two model populations:
EC
TE
D P
RO
OF
ARTICLE IN PRESS
1
3
5
7
9
11
13
15
17
19
21
23
25
27
29
31
33
35
37
39
41
43
45
47
49
51
53
55
57
59
61
63
65
67
69
71
73
75
77
79
81
83
85
87
89
91
93
95
97
99
101
103
105
Fig. 6. Equilibria and convergence for the temporary-partial immunity model. (a), (c) and (e) endemic equilibrium as a function of a and s for three
values of R0 (3:5;=4:0;=4:5) indicating whether convergence is by damped oscillations (light grey) or linear decay (dark grey); (b), (d) and (f)
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RRpopulation A below the eradication threshold; andpopulation B above the eradication threshold.The main observation from these results is that
waning of immunity is a major obstacle to the
eradication of infectious diseases. This is illustrated
here with a situation where immunity lasts, on average,
55 years and the average lifetime is 70 years. The
deterministic models used here predict that, in this
scenario, eradication is possible only if R0 is below 1.84.
Further investigations with discrete stochastic models
may give more optimistic results, but this is beyond the
scope of this paper.107
109
1115. Partial immune protection and vaccination
Here, we illustrate the impact of mass vaccination at
birth in the case where both infection and vaccinationinduce partial protection. First, we consider the simplest
situation of a vaccine that induces as much protection as
a previous infection. Then we analyse the impact of
more efﬁcacious vaccines.
5.1. The reinfection threshold
Before describing vaccination models, we elaborate
on a concept that will be crucial to the analysis—the
‘‘reinfection threshold’’. The full line of Fig. 8 shows
how the endemic equilibrium increases with R0 when
s=0.25, revealing a steep increase as transmission
crosses
R0s ¼
1
s
which in this case is R0=4. This increase is associated
with the reinfection threshold. The dotted and dashed
UN
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Fig. 7. Temporary protection the global impact of mass vaccination.
The rate of loss of immune protection is ﬁxed by setting a=0.0015,
implying that the average duration of protection of 55 years. (a) shows
endemic equilibrium of model (7) as a function of R0: without
vaccination (higher full curve), with 90% vaccination coverage (lower
full curve), and with 100% vaccination coverage (dashed curve). The
dots A and B represent two model population with different R0:
eradication is possible in A, but not in B. (b) simulates the
implementation of a vaccination programme (with 90% coverage) on
both populations.
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Fig. 8. The reinfection threshold. The full line shows the endemic
equilibrium of model (5) as a function of R0. The dotted line
corresponds to the SIR submodel dS/dt=eR0ISeS; dI/dt=R0ISI
and represents primary infection. The submodel sets the invasion
threshold at R0=1. The dashed line corresponds to the SIS submodel
dI/dt=sR0I(1I)I and represents reinfection. By ﬁxing s=0.25, the
reinfection threshold is set at R0=1/s=4.
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primary infection and reinfection to the overall infection
levels, and correspond to the equilibria of two sub-D P
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models: the dotted line corresponds to the SIR model
dS/dt=eR0ISeS; dI/dt=R0ISI and represents pri-
mary infection; and the dashed line corresponds to the
SIS model dI/dt=sR0I(1I)I and represents reinfec-
tion. The invasion threshold (R0=1) is associated with
the primary infection submodel, and the reinfection
threshold (R0=4) is associated with the reinfection
submodel. The full model combines the two dynamical
processes, and reveals the potential to convert small
baseline variabilities of the transmissibility parameter,
R0, into large variabilities of infection prevalence.
5.2. Vaccine inducing protection equivalent to natural
infection
The ﬁrst vaccination model corresponds to a vaccine
that induces an immune response equivalent to that
induced by a previous infection. This is formalized by
the system of equations
dS
dt
¼ ð1 vÞe R0IS  eS;
dI
dt
¼ R0IðS þ sð1 S  IÞÞ  I ; ð8Þ
where v is the vaccination coverage. Fig. 9(a) and (c)
illustrates the effect of mass vaccination in this scenario.
Note that such a vaccine is protective against primary
infection, but not against reinfection. Primary infection
is associated with the susceptibility pool S; and
reinfection associated with the susceptibility pool
S+R. Vaccination moves individuals from S to R and
therefore, essentially reduces the resource for primary
infections without directly affecting reinfection. There-
fore, it is expected that a mass vaccination programme
will be effective below the reinfection threshold, but not
above. This is evident from Fig. 9(a), where we show the
equilibria without vaccination and with 90% vaccina-
tion coverage (full lines). The dashed line corresponds
the unrealistic limit of 100% vaccination coverage.
Three model populations are marked: population A is
below the reinfection threshold and infection eradica-
tion is expected with the 90% vaccination programme;
population B is also below the reinfection threshold and
although 90% coverage is not sufﬁcient for eradication,
a substantial reduction in prevalence is expected;
population C is above the reinfection threshold and
the vaccination programme has only a minor effect on
the equilibrium prevalence. Fig. 9(c) shows the results of
simulating vaccination on the three populations.
The main outcome of this analysis is to demonstrate
with a simple model how a vaccination programme can
have such variable outcomes. Tuberculosis and the
bacille Calmette-Gu!erin (BCG) vaccine constitute the
best documented example of this phenomenon, and this
is further discussed in (Gomes et al., 2004a). The
variability associated with the reinfection threshold
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Fig. 9. Partial protection and the global impact of mass vaccination. Using the endemic equilibria of Fig. 8 as baseline pre-vaccination states, we
illustrate the impact of two vaccination programmes: (a) and (c) show the result of 90% coverage with a vaccine that confers as much protection as
natural infection (model (8)); (b) and (d) show the result of 90% coverage with a vaccine that is more potent than natural infection (model (9) with
sV ¼ 0:2 ). The second vaccine increases the reinfection threshold generating spectacular outcomes in high burden regions that were insensitive to the
ﬁrst vaccine (e.g. population C).
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presents serious difﬁculties to the estimation of vaccine
efﬁcacy from ﬁeld observations, which led to great
controversy concerning the use of BCG.
5.3. Vaccine inducing greater protection natural infection
A sound understanding of susceptibilities to infection
and reinfection is essential to predict the impact of
vaccination programmes when immunity is partially
protective. The hope is that, where transmissibility is
above the reinfection threshold, vaccines that protect
more than a natural infection might prove much more
effective. This can be demonstrated with the model
dS
dt
¼ ð1 vÞe R0IS  eS;
dIS
dt
¼ R0IðS þ sRÞ  IS;
dR
dt
¼ ð1 eÞIS  sR0IR eR;
dV
dt
¼ veþ ð1 eÞIV  sVR0IV  eV ;
dI
dt
¼ sVR0IV  IV ; ð9Þ
where sV is the factor by which vaccination reduces
susceptibility, and here we consider sVos. Fig. 9(b) and
(d) illustrates the effect of such vaccine when s=0.25 as
before and sV=0.2. The full lines in Fig. 9(b) represent
the pre-vaccination state (as before) and the post-D Pvaccination equilibrium with 90% coverage. We seethat the range of R0 where this vaccine has the potentialto be highly effective has increased, going up to 1/sV,
which is R0=5 in this case. In other words, if vaccine
protection is higher than naturally acquired protection
(sVos) then vaccination has the power to increase the
reinfection threshold to
R0V ¼
1
sV
:
From the three model populations used before, it is
population C (where endemicity is highest) who would
beneﬁt the most with the development of such vaccine.
Fig. 9(d) shows the simulations of the vaccination
programme from the time it is introduced until the new
equilibrium is reached.
These results have important implications for public
health. A great challenge of vaccine development is to
supersede the protection provided by natural infection.
The reinfection threshold magniﬁes epidemiological
variabilities, but perhaps the most exciting news is that
this threshold can be manipulated by vaccines. Vaccines
that protect more than naturally acquired infection
increase the threshold for reinfection, and may have
greater impact than expected in regions afﬂicted by high
burdens of disease. In the case of tuberculosis, a number
of strategies for the development of better vaccines are
being followed (Britton and Palendira, 2003; Olsen and
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cannot be overemphasized (Gomes et al., 2004a).E
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6. Discussion
Since the majority of pathogen infections involve
reinfection, the dynamic consequences of any interven-
tion on rates of (re)infection should be considered. We
suggest that most infections can be classiﬁed according
to the relative signiﬁcance of partial and temporary
immunity in creating susceptibility to reinfection (Fig.
5). Temporary immunity is, to a large extent, determined
by the propensity for antigenic change, but also
alteration in host status (e.g. immunosuppression due
to other infections). Partial immunity is more dependent
on the interaction between static host and pathogen
variation: high parasite variation decreasing partial
immunity, and high host variation increasing partial
immunity. As rates of antigenic change will depend on
the variability in the population, one might expect that
pathogens occupy the diagonal region in Fig. 5.
The exact mechanism by which individuals regain
susceptibility following infection has an important
inﬂuence on the level of infection maintained in the
population and on the potential periodicity of epi-
demics. Fig. 4(a) and (b) suggests that waning of
immunity has a crucial impact on the time-scale for
potential inter-epidemic periods. Fig. 4(c) and (d)
reveals two clearly distinct types of endemic behaviour:
low and high. The ﬁrst requires that transmissibility is
just above R0=1. The second relies on reinfection and
requires that transmissibility is above R0=1/s. Further-
more, the different mechanisms of immunity failure
impact differentially on control strategies.
Many diseases are subject to seasonal forcing of
transmission, and this has motivated extensive investi-
gations for the SIR scenario (Keeling et al., 2001).
Basically, the resulting inter-epidemic period is inferred
from the interplay of the annual cycle and the period of
the damped oscillations (Weber et al., 2001). Here we
observe that the period for damped oscillations is highly
sensitive to the mode of action of immune protection
(especially temporary immunity). A combination of
these mechanisms with seasonality may be necessary to
explain time-scales observed in epidemic cycles.
A more realistic scenario is to consider many levels of
susceptibility to infection, or even a continuum. This has
been previously implemented (White and Medley, 1998)
but analysis has been limited by model complexity. In
cases of antigenic diversity, the dynamics of immunity
should somewhat correlate with the pathogen evolution,
and this has been explored to some extent (Gomes et al.,
2002, 2004b; Gog and Grenfell, 2002; Ferguson et al.,
2003). In the context of Trypanosoma infections, Coen
et al. (2001) attempted to estimate the rate of loss ofD P
RO
OF
immunity from seroprevalence data. However, unless
primary infection can be distinguished from subsequent
infection in some manner (e.g. antibody proﬁle), the
parameters for infection rate and immunity loss will be
colinear, complicating statistical analysis. A further
complication is that the risk of disease on infection
might be higher for primary infection (e.g. RSV), or
increase with time since last infection or be determined
by pathogen (genetic) type. Consequently, the impacts
that we show in terms of prevalence and incidence of
infection might be different from prevalence and
incidence of disease. We have also assumed that
subsequent infections are as infectious as primary
infections, which is also unlikely to be generally true.
The incidence of pulmonary tuberculosis can vary by
two orders of magnitude between different regions of
the world, and estimates for the efﬁcacy of the BCG
vaccine vary between 0% and 80%. This scenario is
aggravated by an association between high prevalence of
infection and low vaccine efﬁcacy (Olsen and Andersen,
2003). It is reasonable to expect vaccination pro-
grammes to be less successful in highly endemic regions,
and all models discussed here show this effect to some
extent. However, the extreme variabilities observed in
TB and BCG efﬁcacy are a speciﬁcity of the partial
immune protection mechanism, due to the reinfection
threshold. We have recently proposed this mechanism as
an explanation for the BCG discrepancies (Gomes et al.,
2004a). Here we show that the conclusions are not
speciﬁc to tuberculosis but rather, they are a general
feature of diseases characterized by partial immune
protection and the associated reinfection threshold.
The reinfection threshold represents the transmissi-
bility required to promote recurrent infections. Popula-
tions that exceed this threshold, sustain high levels of
infection and tend to be insensitive to interventions.
Furthermore, the reinfection threshold can be poten-
tially manipulated by vaccination. Vaccines that induce
more protection than a natural infection increase the
reinfection threshold, providing means for the control of
recurrent infection in high-burden regions. Conse-
quently, the partial immune protection framework can
serve as a basis to assess the impact of speciﬁc vaccines,
and to set targets for future vaccine performance in
terms of their epidemiological impact (McLean, 1995b).
While such vaccines are currently unavailable, efforts
can be exerted into manipulating transmission. That is,
in populations of high endemicity, improvements in
hygiene or reduced crowding could reduce the risk of
transmission and therefore the basic reproduction
number. If the basic reproduction number is reduced
below the reinfection threshold, there would be resulting
a drop in prevalence of infection and an increase in
apparent vaccination effectiveness.
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